CORT
Corcept Therapeutics Incorporated
118.50$
+4.9%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | – | – | 8,796.6% | 2,637.8% | 9,514.8% | 69,893.1% | – | – | 2.8% | 1.4% | 3.3% | 2.7% | 2.5% | 2.2% | 2.1% | 1.8% | 1.6% | 1.4% | 1.3% | 1.3% | 1.6% | 1.7% | |
| – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | – | – | 97.2% | 98.6% | 96.7% | 97.3% | 97.5% | 97.8% | 97.9% | 98.2% | 98.4% | 98.6% | 98.7% | 98.7% | 98.4% | 98.3% | |
| – | – | – | – | – | – | 7,086.4% | 1,630.7% | 6,771.3% | 49,662.1% | – | – | 425.6% | 197.6% | 69.2% | 30.7% | 29.3% | 25.4% | 29.9% | 29.0% | 32.4% | 31.1% | 32.6% | 38.2% | 36.6% | 33.5% | |
| – | – | – | – | – | – | 1,715.0% | 1,009.8% | 2,749.3% | 20,265.5% | – | – | 768.5% | 301.6% | 131.5% | 73.5% | 55.6% | 39.2% | 32.4% | 32.7% | 29.8% | 33.4% | 38.0% | 38.2% | 41.5% | 58.9% | |
| – | – | – | – | – | – | 8,801.4% | 2,640.5% | 9,520.6% | 69,927.6% | – | – | 1,194.1% | 499.3% | 200.7% | 104.1% | 85.0% | 64.6% | 62.3% | 61.8% | 62.2% | 64.5% | 70.6% | 76.4% | 78.1% | 92.4% | |
| – | – | – | – | – | – | -8,701.4% | -2,540.5% | -9,420.6% | -69,827.6% | – | – | -1,096.8% | -400.7% | -104.0% | -6.8% | 12.5% | 33.2% | 35.6% | 36.4% | 36.2% | 34.0% | 28.0% | 22.2% | 20.3% | 5.9% | |
| – | – | – | – | – | – | 0.0% | 0.0% | 451.7% | 348.3% | – | – | 53.7% | 43.6% | 14.2% | 5.9% | 2.5% | 0.0% | 1.1% | 1.7% | 1.6% | 1.0% | 0.9% | – | – | – | |
| – | – | – | – | – | – | -8,460.2% | -2,401.0% | -9,598.6% | -69,537.9% | – | – | -1,150.5% | -444.3% | -118.2% | -12.7% | 10.0% | 33.2% | 36.7% | 38.1% | 37.2% | 34.2% | 28.9% | 25.8% | 23.9% | 8.7% | |
| – | – | – | – | – | – | -241.2% | -139.4% | 178.0% | -289.7% | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -47.9% | 6.7% | 7.3% | 7.2% | 3.4% | 3.7% | 3.8% | 3.0% | -4.4% | |
| – | – | – | – | – | – | -8,460.2% | -2,401.0% | -9,598.6% | -69,537.9% | – | – | -1,150.5% | -444.3% | -118.2% | -12.7% | 10.0% | 81.1% | 30.0% | 30.7% | 30.0% | 30.7% | 25.2% | 22.0% | 20.7% | 13.1% | |
| – | – | – | – | – | – | -8,701.4% | -2,540.5% | -9,420.6% | -69,827.6% | – | – | -1,096.0% | -399.9% | -103.5% | -6.5% | 12.6% | 33.3% | 35.7% | 37.1% | 36.9% | 34.9% | 28.8% | 26.0% | 24.1% | 9.0% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.